Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

by Sapino Anna, Martinello Rossella, Beano Alessandra, Jacomuzzi Maria, Nolè Franco, Donadio Michela, Redana Stefania, Viale Giuseppe, Aglietta Massimo, Montemurro Filippo
Published 2010-02-01